Drug recall · May 31, 2023
Lidocaine 2% HCl Inj recall
Why: Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lidocaine 2% HCl Inj, 500mL bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-8091-1, code 7128580911.
- Lots / codes
Lot # 37-870983, Exp 06/10/2023; 37-879653, 37-879654, Exp 07/16/2023; 37-883186, Exp 07/29/2023; 37-888533, Exp 08/20/2023; 37-893416, Exp 09/09/2023
- Quantity
- 1516 bags
- Company
- Central Admixture Pharmacy Services, Inc., Allentown, PA
- Distribution
- Nationwide in the USA.
- Initiated
- April 28, 2023 · Voluntary: Firm initiated
- Classified
- May 19, 2023
- Reported
- May 31, 2023
- Ended
- June 22, 2025
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.